Skip to content

HR-QoL and Sexuality in Mirena Inserted Contraception Users

A Multicenter, Open Labelled, Uncontrolled, Phase IV Clinical Study to Evaluate the Health-related Quality of Life and Sexual Well-being in Young (18-35) Healthy Mirena Users Switching From OC, Over the First Year Post-insertion.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00498784
Enrollment
141
Registered
2007-07-10
Start date
2005-11-30
Completion date
2007-10-31
Last updated
2013-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

Intra-uterine contraception, Intrauterine Devices

Brief summary

The purpose of this study is to evaluate the changes in the quality of life, as well as in the sexual activity, in women inserted with MIRENA, a hormonal contraceptive intra-uterine system, over the first 12 months of use. Patients switching from oral contraception to an intrauterine contraceptive device (here: MIRENA) will be observed in the first year post MIRENA insertion.

Interventions

DRUGMirena

Mirena 52mg during 1 year

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy woman willing to, or having to switch from her OC to another contraceptive method

Exclusion criteria

\- Any contraindication to Mirena insertion/use

Design outcomes

Primary

MeasureTime frame
Health-related QoL score1 year

Secondary

MeasureTime frame
Sexuality Index, treatment satisfaction, usual safety outcomes1 year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026